메뉴 바로가기
주메뉴 바로가기
컨텐츠 바로가기

Company

HISTORY

History of EncuraGen

  • 2021

    06
    • Designated as a BLUE100 Anyang Startup Company

  • 2020

    10
    • Designated as a Big 3 Innovative Company
    09
    • Commenced a pre-clinical study
    06
    • Registered a patent in Japan
      Designated as a company for Big3 Innovative Business Support
    05
    • Registered a Research Center BSL2
    04
    • Registered a patent in EU

  • 2019

    10
    • Registered patent in the USA
    03
    • Applied for patents in the EU, Japan and China

  • 2018

    09
    • Applied for patent in the USA
    03
    • Added “registration of patent in Korea”

  • 2017

    09
    • Approved as an Affiliated Research Center
    07
    • Approved as a Venture Company

  • 2016

    09
    • Lead Molecule confirmation (BHD1028)
    01
    • Established EncuraGen

  • 2015

    05
    • R&D on novel AdipoR agonists
Company CEO Head Office and Research Center
EncuraGen, Inc. Brian Kim (Postcode) 14058, 4th Fl., DS Tower, 72-13, Beolmal-ro, Dongan-gu, Anyang City, Gyeonggi Province